Connexin-43 redistribution and gap junction activation during forced restraint protects against sudden arrhythmic death in rats

Circulation Journal

Volumn 74, Issue 6, 2010, Pages 1087-1095

  Unuma, Kana ^a   Shintani Ishida, Kaori ^b   Tsushima, Kensuke ^c   Shimosawa, Tatsuo ^d   Ueyama, Takashi ^d   Kuwahara, Masayoshi ^e   Yoshida, Ken Ichi ^f  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Arrhythmia; Connexin 43; Emotional stress; Gap junction; Sudden death

Indexed keywords

CARBENOXOLONE; CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL FRACTIONATION; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; GAP JUNCTION; HEART ARRHYTHMIA; HEART PROTECTION; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; IMMOBILIZATION; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PROTEIN LOCALIZATION; QRS COMPLEX; RAT; SUDDEN DEATH; TELEMETRY; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ANIMALS; CONNEXIN 43; DEATH, SUDDEN; GAP JUNCTIONS; MALE; PROTECTIVE AGENTS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; TISSUE DISTRIBUTION; VENTRICULAR FIBRILLATION;

EID: 77953525679     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-1019     Document Type: Article

References (46)

1. Uemura K, Ueyama T, Shintani-Ishida K, Unuma K, Yoshida K. An autopsy report on four sudden cardiac death cases by immobilization. Int Med J 2008; 15: 301-305.
2. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001; 19: 187-191.
3. Lecomete D, Fornes P, Nicolas G. Stressful events as a trigger of sudden death: A study of 43 medico-legal autopsy cases. Forensic Sci Int 1996; 79: 1-10.
4. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355-1361.
5. Lampert R, Joska T, Burg MM, Batsford WP, McPherson CA, Jain D. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002; 106: 1800-1805.
6. Tsuchida M, Kawashiri MA, Teramoto R, Takata M, Sakata K, Omi W, et al. Impact of severe earthquake on the occurrence of acute coronary syndrome and stroke in a rural area of Japan. Circ J 2009; 73: 1243-1247.
7. Selye H. The evolution of the stress concept: Stress and cardiovascular disease. Am J Cardiol 1970; 26: 289-299.
8. Ueyama T. Emotional stress-induced Takotsubo cardiomyopathy: Animal model and molecular mechanism. Ann N Y Acad Sci 2004; 1018: 437-444.
9. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo car-diomyopathy: A new form of acute, reversible heart failure. Circulation 2008; 118: 2754-2762.
10. van Veen AA, van Rijen HV, Opthof T. Cardiac gap junction channels: Modulation of expression and channel properties. Cardiovasc Res 2001; 5: 217-229.
11. Jongsma HJ, Rook MB. Morphology and electrophysiology of cardiac gap junction channels. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology, From Cell to Bedside, 3rd ed. Philadelphia: WB Saunders, 2005; 115-126.
12. Cabo C, Boyden PA. Extracellular space attenuates the effect of gap junctional remodeling on wave propagation: A computational study. Biophys J 2009; 96: 3092-3101.
13. Peters NS, Green CR, Poole-Wilson PA, Severs NJ. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 1993; 88: 864-875.
14. Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res 2004; 62: 426-436.
15. De Groot JR, Coronel R. Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis. Cardiovasc Res 2004; 62: 323-334.
16. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004; 61: 208-217.
17. Kjølbye AL, Dikshteyn M, Eloff BC, Deschenes I, Rosenbaum DS. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans. Am J Physiol Heart Circ Physiol 2008; 294: H41-H49.
18. Sasano C, Honjo H, Takagishi Y, Uzzaman M, Emdad L, Shimizu A, et al. Internalization and dephosphorylation of connexin43 in hypertrophied right ventricles of rats with pulmonary hypertension. Circ J 2007; 71: 382-389
19. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001; 88: 333-339.
20. Danik SB, Liu F, Zhang J, Suk HJ, Morley GE, Fishman GI, et al. Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res 2004; 95: 1035-1041.
21. Danik SB, Rosner G, Lader J, Gutstein DE, Fishman GI, Morley GE. Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts. FASEB J 2008; 22: 1204-1212.
22. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 2000; 101: 547-552.
23. Walker ML, Rosenbaum DR. Repolarization alternans: Implication for the mechanism and prevention of sudden cardiac death. Cardio-vasc Res 2003; 57: 599-614.
24. Clustin WT. Mechanism of calcium transient and action potential alternans in cardiac cells and tissues. Am J Physiol 2008; 294: H1-H10.
25. Kuwahara M, Chiku K, Shiono T, Tsubone H, Sugano S. ECG changes under hyperkalemia with nephrectomy in the rat. J Electro-cardiol 1992; 25: 215-219.
26. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, et al. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 1988; 22: 447-455.
27. Kawata H, Yoshida K, Kawamoto A, Kurioka H, Takase E, Sasaki Y, et al. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 2001; 88: 696-704.
28. Shintani-Ishida K, Unuma K, Yoshida K. Ischemia enhances trans-location of connexin43 and gap junction intercellular communication, thereby propagating contraction band necrosis after reper-fusion. Circ J 2009; 73: 1661-1668.
29. Ruiz-Meana M, Garcia-Dorado D, Lane S, Pina P, Inserte J, Mirabet M, et al. Persistence of gap junction communication during myo-cardial ischemia. Am J Physiol Heart Circ Physiol 2001; 280: H2563-H2571.
30. Miura T, Ohnuma Y, Kuno A, Tanno M, Ichikawa Y, Nakamura Y, et al. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol 2004; 286: H214-H221.
31. Gray R, Dhillon PS, Hussain W. Carbenoxolone is a specific gap-junctional uncoupler that leads to reduced conduction velocity and increased intracellular resistivity in cardiac tissue. Heart Rhythm 2005; 2: 706.
32. Kojodjojo P, Kanagaratnam P, Segal OR, Hussain W, Peters NS. The effects of carbenoxolone on human myocardial conduction: A tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis. J Am Coll Cardiol 2006; 48: 1242-1249.
33. de Groot JR, Veenstra T, Verkerk AO, Wilders R, Smits JP, Wilms-Schopman FJ, et al. Conduction slowing by the gap junctional uncoupler carbenoxolone. Cardiovasc Res 2003; 60: 288-297.
34. Sewell KJ, Shirley DG, Michael AE, Thompson A, Norgate DP, Unwin RJ. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion. Clin Sci (Lond) 1998; 95: 435-443.
35. Inoue N, Ohkusa T, Nao T, Lee JK, Matsumoto T, Hisamatsu Y, et al. Rapid electrical stimulation of contraction modulates gap junction protein in neonatal rat cultured cardiomyocytes: Involvement of mitogen-activated protein kinases and effects of angiotensin II-receptor antagonist. J Am Coll Cardiol 2004; 44: 914-922.
36. Suzuki S, Ohkusa T, Sato T, Yoshida M, Yasui K, Miwa K, et al. Effects of aldosterone on Cx43 gap junction expression in neonatal rat cultured cardiomyocytes. Circ J 2009; 73: 1504-1512.
37. Zeevi-Levin N, Barac YD, Reisner Y, Reiter I, Yaniv G, Meiry G, et al. Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2005; 66: 64-73.
38. Salameh A, Krautblatter S, Baessler S, Karl S, Rojas Gomez D, Dhein S, et al. Signal transduction and transcriptional control of cardiac connexin43 up-regulation after alpha 1-adrenoceptor stimulation. J Pharmacol Exp Ther 2008; 326: 315-322.
39. Martin PE, Evans WH. Incorporation of connexins into plasma membranes and gap junctions. Cardiovasc Res 2004; 62: 378-387.
40. Leaf DE, Feig JE, Vasquez C, Riva PL, Yu C, Lader JM, et al. Connexin40 imparts conduction heterogeneity to atrial tissue. Circ Res 2008; 103: 1001-1008.
41. Coppen SR, Dupont E, Rothery S, Severs NJ. Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 1998; 82: 232-243.
42. Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol 2004; 287: H1762-H1770.
43. van Rijen HV, Eckardt D, Degen J, Theis M, Ott T, Willecke K, et al. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation 2004; 109: 1048-1055.
44. Chou CC, Zhou S, Hayashi H, Nihei M, Liu YB, Wen MS, et al. Remodelling of action potential and intracellular calcium cycling dynamics during subacute myocardial infarction promotes ventricular arrhythmias in Langendorff-perfused rabbit hearts. J Physiol 2007; 580: 895-906.
45. Liu N, Priori SG. Disruption of calcium homeostasis and arrhyth-mogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrin. Cardiovasc Res 2008; 77: 293-301.
46. 2+ release kinetics during beta-adrenergic stimulation. J Mol Cell Cardiol 2007; 43: 281-291.